Humana (NYSE:HUM) Updates FY 2024 Earnings Guidance

Humana (NYSE:HUM) issued an update on its FY 2024 earnings guidance on Sunday morning. The company provided earnings per share (EPS) guidance of 16.000-16.000 for the period, compared to the consensus estimate of 16.360. The company issued revenue guidance of -.

Humana Trading Down 0.4 %

HUM traded down $1.24 during trading on Wednesday, reaching $323.39. 687,663 shares of the company’s stock were exchanged, compared to its average volume of 1,960,051. The firm has a fifty day moving average price of $323.08 and a two-hundred day moving average price of $385.94. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $38.97 billion, a PE ratio of 20.16, a price-to-earnings-growth ratio of 1.86 and a beta of 0.49. Humana has a one year low of $298.61 and a one year high of $541.21.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period in the prior year, the firm earned $9.38 earnings per share. As a group, equities research analysts forecast that Humana will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. Humana’s dividend payout ratio is currently 22.04%.

Analysts Set New Price Targets

HUM has been the topic of a number of recent research reports. Jefferies Financial Group dropped their price target on Humana from $411.00 to $381.00 and set a buy rating on the stock in a research report on Monday, April 22nd. Cantor Fitzgerald reduced their price target on Humana from $391.00 to $360.00 and set a neutral rating for the company in a research report on Thursday, April 25th. Royal Bank of Canada cut their target price on Humana from $415.00 to $353.00 and set an outperform rating for the company in a research note on Thursday, April 25th. Stephens lowered their price target on shares of Humana from $550.00 to $430.00 and set an overweight rating on the stock in a report on Friday, January 26th. Finally, Argus lowered shares of Humana from a buy rating to a hold rating in a report on Wednesday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, Humana has an average rating of Hold and a consensus price target of $424.50.

Insider Buying and Selling at Humana

In other news, Director Jorge S. Mesquita purchased 545 shares of Humana stock in a transaction that occurred on Tuesday, February 20th. The shares were bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.29% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.